Fetoh M, Abdel-Fattah M, Mohamed W, Ramadan L, Afify H
Inflammopharmacology. 2022; 31(1):499-516.
PMID: 36586043
PMC: 9958186.
DOI: 10.1007/s10787-022-01123-7.
Ansarey S
Front Psychiatry. 2021; 12:771144.
PMID: 34916973
PMC: 8668869.
DOI: 10.3389/fpsyt.2021.771144.
Shuey M, Xiang R, Moss M, Carvajal B, Wang Y, Camarda N
Arterioscler Thromb Vasc Biol. 2021; 42(1):35-48.
PMID: 34758633
PMC: 8887835.
DOI: 10.1161/ATVBAHA.121.317071.
Hsia A, Jbeily E, Mendez M, Cunningham H, Biris K, Bang H
Osteoarthritis Cartilage. 2021; 29(12):1709-1719.
PMID: 34653605
PMC: 8678362.
DOI: 10.1016/j.joca.2021.09.014.
Goldshtein H, Muhire A, Petel Legare V, Pushett A, Rotkopf R, Shefner J
Ann Clin Transl Neurol. 2020; 7(10):1883-1897.
PMID: 32915525
PMC: 7545590.
DOI: 10.1002/acn3.51174.
In vivo study of pro-inflammatory cytokine changes in serum and synovial fluid during treatment with celecoxib and etoricoxib and correlation with VAS pain change and synovial membrane penetration index in patients with inflammatory arthritis.
Theodoridou A, Gika H, Diza E, Garyfallos A, Settas L
Mediterr J Rheumatol. 2020; 28(1):33-40.
PMID: 32185252
PMC: 7045925.
DOI: 10.31138/mjr.28.1.33.
Short-term supplementation of celecoxib-shifted butyrate production on a simulated model of the gut microbial ecosystem and ameliorated in vitro inflammation.
Hernandez-Sanabria E, Heiremans E, Arroyo M, Props R, Leclercq L, Snoeys J
NPJ Biofilms Microbiomes. 2020; 6(1):9.
PMID: 32075981
PMC: 7031363.
DOI: 10.1038/s41522-020-0119-0.
Molecular docking and pharmacological/toxicological assessment of a new compound designed from celecoxib and paracetamol by molecular hybridization.
da Silva D, Florentino I, da Silva D, Lino R, Cardoso C, Moreira L
Inflammopharmacology. 2018; 26(5):1189-1206.
PMID: 30039481
DOI: 10.1007/s10787-018-0516-7.
CD24 Expression Is Increased in 5-Fluorouracil-Treated Esophageal Adenocarcinoma Cells.
Jimenez P, Chueca E, Arruebo M, Strunk M, Solanas E, Serrano T
Front Pharmacol. 2017; 8:321.
PMID: 28611669
PMC: 5447731.
DOI: 10.3389/fphar.2017.00321.
Non-Steroidal Anti-Inflammatory Drugs and Brain Inflammation: Effects on Microglial Functions.
Ajmone-Cat M, Bernardo A, Greco A, Minghetti L
Pharmaceuticals (Basel). 2016; 3(6):1949-1965.
PMID: 27713336
PMC: 4033961.
DOI: 10.3390/ph3061949.
[DGRh recommendations for the implementation of current security aspects in the NSAID treatment of musculoskeletal pain].
Bolten W, Kruger K, Reiter-Niesert S, Stichtenoth D
Z Rheumatol. 2016; 75(1):103-16.
PMID: 26768271
DOI: 10.1007/s00393-015-0018-6.
Age-Dependent Changes in the Inflammatory Nociceptive Behavior of Mice.
King-Himmelreich T, Moser C, Wolters M, Olbrich K, Geisslinger G, Niederberger E
Int J Mol Sci. 2015; 16(11):27508-19.
PMID: 26593904
PMC: 4661899.
DOI: 10.3390/ijms161126041.
Celecoxib increases lung cancer cell lysis by lymphokine-activated killer cells via upregulation of ICAM-1.
Schellhorn M, Haustein M, Frank M, Linnebacher M, Hinz B
Oncotarget. 2015; 6(36):39342-56.
PMID: 26513172
PMC: 4770776.
DOI: 10.18632/oncotarget.5745.
A Randomized, Double-blind, Placebo-controlled Trial of Celecoxib Augmentation of Sertraline in Treatment of Drug-naive Depressed Women: A Pilot Study.
Majd M, Hashemian F, Hosseini S, Vahdat Shariatpanahi M, Sharifi A
Iran J Pharm Res. 2015; 14(3):891-9.
PMID: 26330878
PMC: 4518118.
[Pharmacological aspects of pain research in Germany].
Niederberger E, Kuner R, Geisslinger G
Schmerz. 2015; 29(5):531-8.
PMID: 26294077
DOI: 10.1007/s00482-015-0042-0.
Celecoxib Inhibits the Lytic Activation of Kaposi's Sarcoma-Associated Herpesvirus through Down-Regulation of RTA Expression by Inhibiting the Activation of p38 MAPK.
Chen J, Jiang L, Lan K, Chen X
Viruses. 2015; 7(5):2268-87.
PMID: 25951487
PMC: 4452905.
DOI: 10.3390/v7052268.
Celecoxib Up Regulates the Expression of Drug Efflux Transporter ABCG2 in Breast Cancer Cell Lines.
Kalalinia F, Elahian F, Mosaffa F, Behravan J
Iran J Pharm Res. 2015; 13(4):1393-401.
PMID: 25587329
PMC: 4232806.
Synergistic analgesia of duloxetine and celecoxib in the mouse formalin test: a combination analysis.
Sun Y, Dong Y, Wang Y, Zhao G, Lu G, Yang J
PLoS One. 2013; 8(10):e76603.
PMID: 24116126
PMC: 3792058.
DOI: 10.1371/journal.pone.0076603.
Sulindac activates NF-κB signaling in colon cancer cells.
Mladenova D, Pangon L, Currey N, Ng I, Musgrove E, Grey S
Cell Commun Signal. 2013; 11:73.
PMID: 24083678
PMC: 3896984.
DOI: 10.1186/1478-811X-11-73.
Triggering of suicidal erythrocyte death by celecoxib.
Lupescu A, Bissinger R, Jilani K, Lang F
Toxins (Basel). 2013; 5(9):1543-54.
PMID: 24025609
PMC: 3798872.
DOI: 10.3390/toxins5091543.
